Analysts expect Castle Biosciences Inc to report revenue of 107.96 M for Q4 26, against a range of 97.74 M to 118.19 M. The most recent reported quarter, Q3 26, came in at 101.95 M, a 13.1% beat against the 90.15 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 85.82 M | 87.20 M | 86.18 M | 83.04 M | 87.01 M | 84.23 M | 103.55 M | 101.95 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 87.40 M | 89.09 M | 80.85 M | 78.14 M | 82.67 M | 80.69 M | 87.14 M | 95.21 M | 118.19 M | 101.22 M | 116.69 M | 119.74 M | 114.02 M | 124.09 M | 140.68 M | 136.03 M | |||||||||
| Low Estimate | 72.65 M | 81.65 M | 67.00 M | 71.32 M | 72.71 M | 72.31 M | 76.38 M | 85.10 M | 97.74 M | 88.47 M | 105.53 M | 110.45 M | 105.38 M | 107.91 M | 119.99 M | 126.24 M | |||||||||
| Consensus Estimate | 80.02 M | 85.37 M | 73.92 M | 74.73 M | 77.69 M | 76.50 M | 81.76 M | 90.15 M | 107.96 M | 94.85 M | 111.11 M | 115.09 M | 109.70 M | 116.00 M | 130.33 M | 131.14 M |
Analysts expect Castle Biosciences Inc to report earnings per share of -0.14 for Q4 26, against a range of -0.15 to -0.13. The most recent reported quarter, Q3 26, came in at -0.13, a 63.9% beat against the -0.36 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.32 | -0.90 | 0.15 | -0.02 | -0.08 | -0.49 | -0.07 | -0.13 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.05 | -0.07 | -0.49 | -0.49 | -0.24 | -0.44 | -0.37 | -0.35 | -0.13 | -0.27 | -0.17 | -0.09 | -0.16 | -0.22 | 0.11 | 0.11 | |||||||||
| Low Estimate | 0.05 | -0.07 | -0.59 | -0.53 | -0.26 | -0.50 | -0.41 | -0.37 | -0.15 | -0.31 | -0.19 | -0.11 | -0.16 | -0.26 | 0.09 | 0.09 | |||||||||
| Consensus Estimate | 0.05 | -0.07 | -0.54 | -0.51 | -0.25 | -0.47 | -0.39 | -0.36 | -0.14 | -0.29 | -0.18 | -0.10 | -0.16 | -0.24 | 0.10 | 0.10 |
Pull Wall Street consensus for Castle Biosciences Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CSTL&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CSTL", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CSTL&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();